ARTICLE | Clinical News
Alteon halts enrollment in alagebrium trials
February 25, 2005 2:17 AM UTC
ALT said it temporarily stopped enrolling new patients in three trials of alagebrium, including two Phase IIa trials in heart failure and erectile dysfunction and a Phase IIb study in hypertension. AL...